SG11202101611TA - Controlled-release urethane-elastomers for use in implantable products - Google Patents
Controlled-release urethane-elastomers for use in implantable productsInfo
- Publication number
- SG11202101611TA SG11202101611TA SG11202101611TA SG11202101611TA SG11202101611TA SG 11202101611T A SG11202101611T A SG 11202101611TA SG 11202101611T A SG11202101611T A SG 11202101611TA SG 11202101611T A SG11202101611T A SG 11202101611TA SG 11202101611T A SG11202101611T A SG 11202101611TA
- Authority
- SG
- Singapore
- Prior art keywords
- elastomers
- controlled
- release urethane
- implantable products
- implantable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C67/00—Shaping techniques not covered by groups B29C39/00 - B29C65/00, B29C70/00 or B29C73/00
- B29C67/24—Shaping techniques not covered by groups B29C39/00 - B29C65/00, B29C70/00 or B29C73/00 characterised by the choice of material
- B29C67/246—Moulding high reactive monomers or prepolymers, e.g. by reaction injection moulding [RIM], liquid injection moulding [LIM]
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y80/00—Products made by additive manufacturing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C64/00—Additive manufacturing, i.e. manufacturing of three-dimensional [3D] objects by additive deposition, additive agglomeration or additive layering, e.g. by 3D printing, stereolithography or selective laser sintering
- B29C64/10—Processes of additive manufacturing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y10/00—Processes of additive manufacturing
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862720412P | 2018-08-21 | 2018-08-21 | |
US201962872793P | 2019-07-11 | 2019-07-11 | |
PCT/US2019/047533 WO2020041489A1 (en) | 2018-08-21 | 2019-08-21 | Controlled-release urethane-elastomers for use in implantable products |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202101611TA true SG11202101611TA (en) | 2021-03-30 |
Family
ID=67902583
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202101611TA SG11202101611TA (en) | 2018-08-21 | 2019-08-21 | Controlled-release urethane-elastomers for use in implantable products |
Country Status (6)
Country | Link |
---|---|
US (3) | US10918764B2 (en) |
EP (1) | EP3840732A1 (en) |
CN (1) | CN112584822A (en) |
CA (1) | CA3110222A1 (en) |
SG (1) | SG11202101611TA (en) |
WO (1) | WO2020041489A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG11202101611TA (en) * | 2018-08-21 | 2021-03-30 | Secant Group Llc | Controlled-release urethane-elastomers for use in implantable products |
EP4188323A1 (en) * | 2020-07-29 | 2023-06-07 | The Secant Group, LLC | Shape-guided controlled release and retention with structures including crosslinked poly(glycerol sebacate) |
WO2022094261A1 (en) | 2020-11-02 | 2022-05-05 | The Secant Group, Llc | Poly(glycerol sebacate) urethane fibers, fabrics formed therefrom, and methods of fiber manufacture |
US20220211904A1 (en) | 2021-01-06 | 2022-07-07 | The Secant Group, Llc | Poly(glycerol sebacate) urethane elastomeric leaflet for heart valve replacement |
WO2023164052A1 (en) * | 2022-02-24 | 2023-08-31 | The Secant Group, Llc | Urethane-crosslinked poly(glycerol sebacate) microparticles and processes of manufacturing the same |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6500239B2 (en) | 2001-03-14 | 2002-12-31 | Penjet Corporation | System and method for removing dissolved gas from a solution |
US7722894B2 (en) | 2001-10-22 | 2010-05-25 | Massachusetts Institute Of Technology | Biodegradable polymer |
US20090208540A1 (en) | 2003-08-11 | 2009-08-20 | Indevus Pharmaceuticals, Inc. | Implantable device for the delivery of naltrexone and methods of use thereof |
KR101250703B1 (en) * | 2004-09-03 | 2013-04-03 | 다우 글로벌 테크놀로지스 엘엘씨 | Blocked Isocyanates and Their Use in Coating Compositions |
WO2007082305A2 (en) | 2006-01-12 | 2007-07-19 | Massachusetts Institute Of Technology | Biodegradable elastomers |
US7923486B2 (en) | 2007-10-04 | 2011-04-12 | Board Of Regents, The University Of Texas System | Bio-polymer and scaffold-sheet method for tissue engineering |
CN101597470B (en) | 2008-06-03 | 2012-05-23 | 北京高盟燕山科技有限公司 | Solvent free bi-component polyurethane adhesive and preparation method thereof |
US10035871B2 (en) * | 2011-08-26 | 2018-07-31 | Massachusetts Institute Of Technology | Urethane-crosslinked biodegradable elastomers |
WO2014160744A1 (en) | 2013-03-26 | 2014-10-02 | Innovia Llc | Pacemaker lead and other medical implant devices |
WO2015184313A1 (en) | 2014-05-30 | 2015-12-03 | Secant Medical, Inc. | Water-mediated preparations of polymeric materials |
CA3015510A1 (en) | 2016-02-25 | 2017-08-31 | The Secant Group, Llc | Composite containing poly(glycerol sebacate) filler |
CN106866929A (en) * | 2017-02-24 | 2017-06-20 | 中国林业科学研究院林产化学工业研究所 | A kind of polyfunctionality castor oil-base light-cured resin and its preparation method and application |
SG11202101611TA (en) * | 2018-08-21 | 2021-03-30 | Secant Group Llc | Controlled-release urethane-elastomers for use in implantable products |
-
2019
- 2019-08-21 SG SG11202101611TA patent/SG11202101611TA/en unknown
- 2019-08-21 CN CN201980054803.6A patent/CN112584822A/en active Pending
- 2019-08-21 EP EP19765835.4A patent/EP3840732A1/en active Pending
- 2019-08-21 WO PCT/US2019/047533 patent/WO2020041489A1/en unknown
- 2019-08-21 CA CA3110222A patent/CA3110222A1/en active Pending
- 2019-08-21 US US16/547,175 patent/US10918764B2/en active Active
-
2021
- 2021-01-13 US US17/148,130 patent/US11406732B2/en active Active
-
2022
- 2022-05-09 US US17/662,462 patent/US11883557B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
WO2020041489A1 (en) | 2020-02-27 |
CA3110222A1 (en) | 2020-02-27 |
US10918764B2 (en) | 2021-02-16 |
EP3840732A1 (en) | 2021-06-30 |
US11883557B2 (en) | 2024-01-30 |
CN112584822A (en) | 2021-03-30 |
US11406732B2 (en) | 2022-08-09 |
US20200061240A1 (en) | 2020-02-27 |
US20210138109A1 (en) | 2021-05-13 |
US20220257828A1 (en) | 2022-08-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU201715314S (en) | Chair | |
CA184715S (en) | Chair | |
CA185967S (en) | Chair | |
SG11202101611TA (en) | Controlled-release urethane-elastomers for use in implantable products | |
AU201816222S (en) | Chair | |
AU201815218S (en) | Chair | |
AU201813360S (en) | Chair | |
AU201815210S (en) | Chair | |
CA185323S (en) | Chair | |
CA186257S (en) | Chair | |
ZAA201801063S (en) | Chair | |
GB201715194D0 (en) | Compounds and their therapeutic use | |
HK1254379A1 (en) | Alkenylphenoxy-substituted 1,1-diphenylethylenes, processes for their preparation, and their use | |
AU201815213S (en) | Chair | |
GB201701400D0 (en) | Compound for use in medicine | |
CA184766S (en) | Chair | |
EP3817628C0 (en) | Chair | |
GB201802122D0 (en) | Product and use | |
CA194193S (en) | Chair | |
CA185243S (en) | Chair | |
EP3411088C0 (en) | Implantable medical products, a process for the preparation thereof, and use thereof | |
IL283273A (en) | Pharmaceutical methods | |
IL268265B (en) | 3-beta-hydroxy-5-alpha-pregnan-20-one for use in medical treatment | |
AU201816054S (en) | Chair | |
AU201816053S (en) | Chair |